1. Home
  2. NCNC vs KAPA Comparison

NCNC vs KAPA Comparison

Compare NCNC & KAPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCNC
  • KAPA
  • Stock Information
  • Founded
  • NCNC 2019
  • KAPA 2013
  • Country
  • NCNC Singapore
  • KAPA United States
  • Employees
  • NCNC N/A
  • KAPA N/A
  • Industry
  • NCNC
  • KAPA
  • Sector
  • NCNC
  • KAPA
  • Exchange
  • NCNC Nasdaq
  • KAPA NYSE
  • Market Cap
  • NCNC 18.4M
  • KAPA 21.3M
  • IPO Year
  • NCNC N/A
  • KAPA 2024
  • Fundamental
  • Price
  • NCNC $0.14
  • KAPA $1.45
  • Analyst Decision
  • NCNC
  • KAPA Strong Buy
  • Analyst Count
  • NCNC 0
  • KAPA 1
  • Target Price
  • NCNC N/A
  • KAPA $9.00
  • AVG Volume (30 Days)
  • NCNC 15.6M
  • KAPA 203.7K
  • Earning Date
  • NCNC 01-01-0001
  • KAPA 11-23-2024
  • Dividend Yield
  • NCNC N/A
  • KAPA N/A
  • EPS Growth
  • NCNC N/A
  • KAPA N/A
  • EPS
  • NCNC N/A
  • KAPA N/A
  • Revenue
  • NCNC N/A
  • KAPA N/A
  • Revenue This Year
  • NCNC N/A
  • KAPA N/A
  • Revenue Next Year
  • NCNC N/A
  • KAPA N/A
  • P/E Ratio
  • NCNC N/A
  • KAPA N/A
  • Revenue Growth
  • NCNC N/A
  • KAPA N/A
  • 52 Week Low
  • NCNC $0.10
  • KAPA $1.22
  • 52 Week High
  • NCNC $0.43
  • KAPA $4.00
  • Technical
  • Relative Strength Index (RSI)
  • NCNC 32.84
  • KAPA N/A
  • Support Level
  • NCNC $0.10
  • KAPA N/A
  • Resistance Level
  • NCNC $0.21
  • KAPA N/A
  • Average True Range (ATR)
  • NCNC 0.01
  • KAPA 0.00
  • MACD
  • NCNC -0.00
  • KAPA 0.00
  • Stochastic Oscillator
  • NCNC 6.09
  • KAPA 0.00

About NCNC noco-noco Inc.

noco-noco Inc is an early-stage decarbonization solution provider in Asia, aiming to engage in the leasing of battery products, including batteries and BEVs to commercial transportation companies, and of ESS to renewable power plants and other power plants requiring grid stabilization and backup power; and (ii) carbon abatement solutions for landowners and carbon credit sales. noco-noco operates own-and-lease business model where it manufactures its battery products through OEMs and leases them to its clients. It also engages in carbon abatement solutions and carbon credit sales and cross-sells them to its battery business clients to offset carbon emissions from their operations.

About KAPA KAIROS PHARMA LTD

Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.

Share on Social Networks: